Search
Cefadroxil
go.drugbank.com/drugs/DB01140ApprovedInvestigationalVet approvedWithdrawnLong-acting, broad-spectrum, water-soluble, cephalexin derivative.
Setiptiline
go.drugbank.com/drugs/DB09304ExperimentalIn Japan, the company Mochida started its commercialization for the treatment of depression started in 1989.
Pozelimab
go.drugbank.com/drugs/DB15218ApprovedInvestigationalCD55-deficient protein-losing enteropathy (PLE), or CHAPLE disease, is an ultra-rare hereditary disease, with fewer than 100 patients diagnosed worldwide or fewer than 10 patients in the US. … autoimmune hemolysis that are often observed in CHAPLE disease.
Tallimustine
go.drugbank.com/drugs/DB15466Experimental[A182036,A182039] It's association with severe myelotoxicity lead to the end of its development in favour of α-halogenoacrylamide derivatives such as [brostallicin], which have a favourable cytotoxicity … Tallimustine, a benzoyl mustard derivative of distamycin A, is an alkylating agent that binds to the minor groove of DNA.
Poloxalene
go.drugbank.com/drugs/DB11451InvestigationalVet approvedEthylene oxide/propylene oxide copolymer is used as a food additive. It belongs to the family of Epoxides. These are compounds containing a cyclic ether with three ring atoms (one oxygen and two carbon atoms).
Categories: Compounds used in a research, industrial, or household setting2,3-Dimercapto-1-propanesulfonic acid
go.drugbank.com/drugs/DB15967InvestigationalCategories: Compounds used in a research, industrial, or household settingt-Butylhydroquinone
go.drugbank.com/drugs/DB07726ExperimentalCategories: Compounds used in a research, industrial, or household settingFelbinac
go.drugbank.com/drugs/DB07477InvestigationalCategories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSINS 316
go.drugbank.com/drugs/DB05390ExperimentalINS316 belongs to the family of drugs called nucleoside triphosphates.It is studied in the diagnosis of lung diseases, including lung cancer.
Abdavomeran
go.drugbank.com/drugs/DB15695Investigational[L15017, L15022] BNT162b1 received fast track designation by the FDA on July 13, 2020.[L15027] … [L15012] BNT162b1 is undergoing further evaluation in clinical trials in both the USA (NCT04368728) and Germany (NCT04380701).